The Lyme disease treatment market is expected to grow by 2031 due to the rising number of Lyme disease cases. The medication sub-segment is predicted to be the most lucrative. The market in
/PRNewswire/ Rise in prevalence of lyme disease in humans as well as animals and awareness of the long-term health impacts for those affected are fueling.
Adoption of medications as first-line treatments of lyme disease and research on antibiotic therapies creating lucrative avenues; growing awareness of incidence and burden of disease in canines
-High prevalence of Lyme disease in animals in developed countries with substantial spending on veterinary care boosts growth of the Lyme disease treatment market -Funding from government